KOSDAQ - Delayed Quote KRW

Englewood Lab, Inc. (950140.KQ)

Compare
6,950.00
-70.00
(-1.00%)
At close: January 17 at 3:30:30 PM GMT+9
Loading Chart for 950140.KQ
DELL
  • Previous Close 7,020.00
  • Open 7,000.00
  • Bid 6,930.00 x --
  • Ask 6,940.00 x --
  • Day's Range 6,860.00 - 7,040.00
  • 52 Week Range 6,410.00 - 28,300.00
  • Volume 128,164
  • Avg. Volume 242,118
  • Market Cap (intraday) 138.082B
  • Beta (5Y Monthly) 0.77
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date --
  • Forward Dividend & Yield 99.80 (1.29%)
  • Ex-Dividend Date Dec 27, 2023
  • 1y Target Est --

Englewood Lab, Inc. engages in the research and development, manufacture, sale, and distribution of cosmetic products in the United States, Canada, China, Korea, Europe, Southeast Asia, and internationally. The company offers skincare products, such as oils, creams, serums, cleansers, and masks; hybrid beauty products, including primers and foundations, BB and CC creams, concealers, blushes and illuminizers, bronzer highlighters, and lip care products; and SPF/ACNE, personal hygiene, and skin protectant over the counter products. The company was founded in 2004 and is headquartered in Totowa, New Jersey.

www.englewoodlab.com

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 950140.KQ

View More

Performance Overview: 950140.KQ

Trailing total returns as of 1/18/2025, which may include dividends or other distributions. Benchmark is

.

YTD Return

950140.KQ
1.91%
MSCI WORLD
1.59%

1-Year Return

950140.KQ
53.91%
MSCI WORLD
21.07%

3-Year Return

950140.KQ
14.09%
MSCI WORLD
0.00%

5-Year Return

950140.KQ
48.35%
MSCI WORLD
56.40%

Compare To: 950140.KQ

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 950140.KQ

View More

Valuation Measures

As of 1/16/2025
  • Market Cap

    139.47B

  • Enterprise Value

    139.56B

  • Trailing P/E

    9.30

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.71

  • Price/Book (mrq)

    1.10

  • Enterprise Value/Revenue

    0.71

  • Enterprise Value/EBITDA

    5.12

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    10.62%

  • Return on Assets (ttm)

    10.98%

  • Return on Equity (ttm)

    18.93%

  • Revenue (ttm)

    210.19B

  • Net Income Avi to Common (ttm)

    22.33B

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    17.26B

  • Total Debt/Equity (mrq)

    10.95%

  • Levered Free Cash Flow (ttm)

    -2.22B

Research Analysis: 950140.KQ

View More

People Also Watch